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Abstract: Melanoma is the most severe of all skin cancers as it may grow rapidly and metastasize. The application of
photodynamic therapy (PDT) opens new perspectives in treatment of this cancer. Numerous studies suggest that the exposure
of tumor cells to PDT can lead to cell death via two separate processes: apoptosis or necrosis. The aim of this study was to
assess in vitro photodynamic therapy which induces apoptosis in the human Beidegröm Melanoma (BM) cell line, using neutral
comet assay. The cells were incubated with Photofrin II (15 μg/ml and 30 μg/ml) 4 h before and 3 h after irradiation for 5 or
10 min with the light intensity of 10 mW/cm2, using a lamp with red filter (632.8 nm). The percentage of apoptotic cells was
significantly higher after PDT comparing to control cells. We observed 25% and 70% of apoptotic cells after shorter irradiation
and treatment with 15 μg/ml and 30 μg/ml of Ph II, respectively. After longer irradiation, the respective values were 71.9%
and 90%. The results suggest that induction of apoptosis is an important determinant of photodynamic sensitivity in the studied
cell line and that some types of DNA damage are dependent on photosensitizer concentration and time of irradiation.
Key words: Photodynamic therapy - Neutral comet assay - Photofrin II - Melanoma - Cell culture
Introduction
Melanoma has been for a long time one of the most
dangerous cancers in Poland. Although it accounts for
only about 4% of all skin cancer cases, this tumor causes
most skin cancer-related deaths, being the most severe
of all skin cancers because of its ability to grow rapidly
and to metastasize. Melanoma can occur in all regions
of the skin, however, it is more common in some regions
e.g. in males on the trunk, while in females on the legs.
Rarely melanomas can occur in eyes, in the nervous
system and in mucous membranes. There is no fully
effective treatment, and 95% of melanoma cases are
treated first with surgery. Other treatments include: che-
motherapy, immunotherapy, radiation therapy and com-
bination of the three [3]. The application of photo-
dynamic therapy (PDT) opens new perspectives in the
therapy of this cancer. PDT is an effective local cancer
treatment that induces cytotoxicity through intracellular
generation of reactive oxygen species (ROS). The inter-
action between the excited photosensitizer and molecu-
lar oxygen yields singlet oxygen (102) as well as other
ROS to induce cell death [6, 18]. The mechanism of
photodynamic reaction in tissues has not been fully
elucidated. The course of changes observed in cells
under the influence of PDT can be different, depending
on the oxygen accessibility, the type of photosensitizer
and its concentration, as well as the intensity of light.
The disintegration of cellular structures and modulation
of genetic information induced by PDT directs cancer
cells to a death pathway [2, 15, 16]. Numerous studies
suggest that the exposure of tumor cells to PDT can lead
to cell death via two separate processes: apoptosis or
necrosis. In contrast to necrosis, apoptosis is an energy
dependent, distinct form of cell death that follows a
sequence of genetically programmed events and pro-
ceeds without inflammation [1, 5]. 
One of several methods of apoptosis detection is the
neutral comet assay which uses single cell gel electro-
phoresis to detect DNA strand breaks in individual mam-
malian cells. The comet assay is a relatively simple
technique that allows to determine not only the percent-
age of apoptotic nuclei, but also the extent of genotoxic
damage induced by an apoptotic trigger [12]. In its
original form, cells embedded in agarose on microscope
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slides are lysed and subjected to electrophoresis under
neutral conditions, enabling the detection of DNA
double strand breaks [4, 6].
This assay can detect various forms of DNA strand
breaks depending on the pH of electrophoresis [6].
Under alkaline conditions (pH 13), it detects single-
strand breaks, double strand breaks, excision repair sites,
and alkaline-labile sites. Under neutral conditions, it
mainly detects double strand DNA breaks [9, 13] and is
therefore considered to be suitable for detection of apop-
tosis [21].
The objective of the present study was to assess in
vitro photodynamic therapy which induces apoptosis in
human Beidegröm Melanoma (BM) cell line.
Materials and methods
Cell culture. Beidegröm Melanoma (BM) cell line, established from
human melanoma, was obtained from the Institute of Immunology
and Experimental Therapy, Polish Academy of Sciences, Wroclaw.
The cells were grown in MEM medium (Sigma) with addition of 10%
foetal bovine serum (Biowhittaker). For experiments, the cells were
removed by trypsinization, and washed with PBS. The cells were
maintained in a humidified atmosphere at 37˚C and 5% CO2.
Photodynamic treatment. The Photofrin II (Ph II, QLT Photother-
apeutics, Inc. Vancouver, Canada), a photosensitizer that has been
accepted for clinical studies, was used for the photodynamic therapy
in vitro. The cells were incubated for 4 h, in the dark, with two doses:
either 15 μg/ml or 30 μg/ml of Ph II in MEM. Then they were
irradiated with the light intensity of 10 mW/cm2 using a lamp
(OPTEL, Opole, Poland) with polarized light and red filter (632.8
nm) and incubated again for 3 h at 37˚C and 5% CO2 in MEM. Two
irradiation times: 5 min and 10 min, equivalent to light doses of 3
J/cm2 and 6 J/cm2, respectively, were tested.
Neutral comet assay. For detection of DNA fragmentation associ-
ated with apoptosis, neutral comet assay method described by Collins
[6] was used. BM cells, at a concentration of 1×105/ml, were mixed
with low temperature melting agarose (Sigma) at ratio 1:10 (v/v) and
spread on a slide. Slides were submerged in precooled lytic solution
(2.5 M NaCl, 100 mM EDTA, pH 10, 10 mM Tris base and 1% Triton
X-100) at 4˚C for 60 min. After lysis and rinsing, slides were
equilibrated in TBE solution (40 mM Tris/boric acid, 2 mM EDTA,
pH 8.3), electrophoresed at 1.0 V/cm2 for 20 min and then silver
staining was performed [10]. For scoring the comet patterns, 100-200
nuclei from each slide were assessed.
To rank apoptotic comets, we followed the method developed by
Collins [6]. We were able to distinguish five types of comets. Figure
1 shows the detailed categorization method used for evaluation of
our samples. For comparison of comet scores we used χ2 test. The
results turned out to be statistically significant, after checking a
hypothesis that the type of comet is dependent on PDT with the
probability of the first kind error α = 0.05.
Results and discussion
In order to determine the phototoxicity of Photofrin
II-mediated PDT, fragmentation of DNA was evaluated.
Neutral comet assay detects only double-stranded DNA
breakage, characteristic of apoptotic death [14, 21].
Under alkaline conditions, DNA denaturation and sep-
aration of double-stranded DNA occur, in contrast to
neutral conditions, where during DNA uncoiling and
following electrophoresis, the denaturation of DNA
does not take place. Therefore, the nuclei with single-
stranded DNA breaks are detected in alkaline method as
comets. However, such nuclei are not observed as co-
mets under neutral conditions, because each damaged
strand is still associated with undamaged one and is
detected as comet type 0 (Fig. 1A, B). The apoptotic cell
Fig. 1. Different kinds of DNA
damage visualized by comet assay.
A - comet type 0 and 2; B - comet
type 0 and 3; C - comet type 1 and
4; D - comet type 1 and 3. Type 0 -
size of the head as normal nucleus
size, tail absent; type 1 - size of the
head as normal nucleus size, tail
size less than normal nucleus size;
type 2 - size of the head as normal
nucleus size, tail size about 1-2
times normal nucleus size; type 3 -
size of the head as normal nucleus
size, tail size about 2-3 times normal
nucleus size; type 4 - size of the
head less than half size of normal
nucleus, tail size more than 3 times
normal nucleus size.
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nuclei are categorized as type 3 or 4 comets (Fig. 1B-D).
Comets of type 1 and 2 (Fig. 1A, C, D) reflect undefined
DNA changes. 
The results are presented in Figure 2. The percentage
of apoptotic cells was significantly higher for cells after
PDT than for control cells (Fig. 2A). We observed 25%
and 70% of apoptotic cells after 3 J/cm2 irradiation and
treatment with 15 μg/ml and 30 μg/ml of Ph II, respec-
tively (Fig. 2B). After 6 J/cm2 irradiation, the respective
values were 71.9% and 90% (Fig. 2C).
The efficiency of photodynamic therapy in the treat-
ment of malignant melanoma is not well defined. Most
studies on PDT effects were focused on those that lead
to cell death [19]. Cell death caused by PDT (through
the generation of ROS) can occur either by apoptosis as
interphase death or as secondary event following mitosis
or by necrosis, depending on the cell type, oxygen level,
concentration and intracellular localization of the sen-
sitizers, and the light dose [1, 7, 20]. The early studies
concerning the influence PDT on melanoma were per-
formed on murine malignant melanoma in vitro and in
vivo using aluminum phtalocyanine (AlpcS4) [2, 8].
PDT was found to have significant effects in this ex-
perimental melanoma and apoptosis induced by PDT
seemed to play an important role in the photodynamic
treatment efficacy [2]. 
The present study shows that Photofrin II PDT in-
duces cell death in BM line mainly through apoptosis.
Gupta et al.  [7] observed differences in sensitivity to
hematoporphyrin derivative HpD (photoscan-3; PS-3)
PDT between human glioma (BMG-1) cell line carrying
wild type tumor suppressor gene p53 and a human
squamous carcinoma cell line (4451) with mutated p53.
They studied PDT-induced apoptosis using alternative
methods (flow cytometric analysis of DNA content,
phosphatidylserine externalization, light-scatter ana-
lysis and fluorescence microscopy). They observed that
PS-3 PDT induced a significantly higher level of apop-
tosis in human glioma (BMG-1) cells as compared to
squamous carcinoma (4451) cells. This was dependent
on the concentration of PS-3 as well as post-irradiation
time in both cell lines. At 2.5 μg/ml of PS-3, the fraction
of BMG-1 cells undergoing apoptosis (60%) was nearly
6-fold higher than that of 4451 cells (10%). The increase
in PS-3 concentration to 5 μg/ml increased apoptosis in
BMG-1 cells, however, further increase in PS-3 concen-
tration to 10 μg/ml caused decrease in the percentage of
apoptotic cells in BMG-1 line but increase in 4451 line [7].
In this study we demonstrated that BM cell sensitivity
to Ph II PDT is dependent on Ph II concentration and
light dose. In contrast to studies of Gupta et al. [7], the
highest percentage of apoptotic cells was achieved at 10
μg/ml Ph II and 10 min of irradiation. Similar results
were obtained in human melanoma cells and a new
silicon phtalocyanine photosensitizer which has the
property of triggering cell apoptosis mediated by mito-
chondria [2]. Nagata et al. [11] performed studies con-
cerning phototoxic effect and cell death modes of human
malignant melanoma cells following photodynamic
therapy with ATX-S10(Na), an amphifilic photosen-
sitizer and demonstrated higher phototoxicity with
higher dye and light doses. Most of the dead cells ap-
peared apoptotic after dye and irradiation doses that
induced less than 70% cytotoxicity. In contrast, most of
cells appeared necrotic after doses that induced 99%
cytotoxicity. These results seem unusual, as the primary
sites of ATX-S10(Na) accumulation were lysosomes,
not mitochon- dria. In our studies we used Ph II as a
photosensitizer which accumulates mainly in the mito-
chondrial membranes [11]. This leads to disturbances of
mitochondrial transmembrane potential and finally to
apoptotic cell death. 
Fig. 2. The percentage of nuclei with DNA damage in BM cells
induced by Photofrin II-mediated PDT. A - control (not irradiated),
B - 15 μg/ml Ph II, C - 30 μg/ml Ph II.  Left histograms in B and C
- 5 min irradiation; right histograms in B and C - 10 min irradiation.
Effect of photodynamic therapy on melanoma cells
The photodynamic therapy was successfully applied
in clinical settings to destroy neoplasms, but the efficacy
of such treatment is dependent on the type of neoplasm
and the photosensitizer. The investigations concerning
the influence of PDT on melanoma in vivo, using chlorin
e(6), demonstrated complete regression in all skin me-
lanoma metastases with no recurrence during the study
period [16]. PDT of melanoma with porphyrin and por-
phyrin derivatives is effective and well tolerated by
patients [17]. The present results show that higher sen-
sitivity to Ph II PDT in BM cells is manifested by higher
level of apoptosis and suggest that induction of apoptosis
is an important determinant of photodynamic sensitivity
in this malignant cell line. The application of comet
assay to study the influence of Photofrin II PDT on BM
cells demonstrated that some types of DNA damage
depend on photosensitizer concentration, as well as on
time and dose of irradiation. 
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